Elevance Health Total Non-Operating Income/Expense 2010-2024 | ELV
Elevance Health annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Elevance Health total non-operating income/expense for the quarter ending September 30, 2024 was $-0.300B, a 15.83% increase year-over-year.
- Elevance Health total non-operating income/expense for the twelve months ending September 30, 2024 was $-1.104B, a 10.4% increase year-over-year.
- Elevance Health annual total non-operating income/expense for 2023 was $-1.03B, a 21.03% increase from 2022.
- Elevance Health annual total non-operating income/expense for 2022 was $-0.851B, a 3.91% increase from 2021.
- Elevance Health annual total non-operating income/expense for 2021 was $-0.819B, a 0.12% decline from 2020.
| Elevance Health Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2023 | $-1,030 |
| 2022 | $-851 |
| 2021 | $-819 |
| 2020 | $-820 |
| 2019 | $-748 |
| 2018 | $-764 |
| 2017 | $-1,021 |
| 2016 | $-723 |
| 2015 | $-644 |
| 2014 | $-682 |
| 2013 | $-748 |
| 2012 | $-512 |
| 2011 | $-430 |
| 2010 | $-419 |
| 2009 | $-447 |
| Elevance Health Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-300 |
| 2024-06-30 | $-280 |
| 2024-03-31 | $-265 |
| 2023-12-31 | $-259 |
| 2023-09-30 | $-259 |
| 2023-06-30 | $-261 |
| 2023-03-31 | $-251 |
| 2022-12-31 | $-229 |
| 2022-09-30 | $-213 |
| 2022-06-30 | $-208 |
| 2022-03-31 | $-201 |
| 2021-12-31 | $-216 |
| 2021-09-30 | $-201 |
| 2021-06-30 | $-210 |
| 2021-03-31 | $-192 |
| 2020-12-31 | $-193 |
| 2020-09-30 | $-228 |
| 2020-06-30 | $-204 |
| 2020-03-31 | $-195 |
| 2019-12-31 | $-193 |
| 2019-09-30 | $-185 |
| 2019-06-30 | $-184 |
| 2019-03-31 | $-186 |
| 2018-12-31 | $-183 |
| 2018-09-30 | $-187 |
| 2018-06-30 | $-191 |
| 2018-03-31 | $-203 |
| 2017-12-31 | $-446 |
| 2017-09-30 | $-150 |
| 2017-06-30 | $-190 |
| 2017-03-31 | $-235 |
| 2016-12-31 | $-177 |
| 2016-09-30 | $-173 |
| 2016-06-30 | $-186 |
| 2016-03-31 | $-187 |
| 2015-12-31 | $-172 |
| 2015-09-30 | $-163 |
| 2015-06-30 | $-151 |
| 2015-03-31 | $-158 |
| 2014-12-31 | $-154 |
| 2014-09-30 | $-230 |
| 2014-06-30 | $-149 |
| 2014-03-31 | $-149 |
| 2013-12-31 | $-146 |
| 2013-09-30 | $-297 |
| 2013-06-30 | $-152 |
| 2013-03-31 | $-154 |
| 2012-12-31 | $-152 |
| 2012-09-30 | $-134 |
| 2012-06-30 | $-118 |
| 2012-03-31 | $-109 |
| 2011-12-31 | $-113 |
| 2011-09-30 | $-108 |
| 2011-06-30 | $-104 |
| 2011-03-31 | $-106 |
| 2010-12-31 | $-113 |
| 2010-09-30 | $-106 |
| 2010-06-30 | $-100 |
| 2010-03-31 | $-99 |
| 2009-12-31 | $-104 |
| 2009-09-30 | $-111 |
| 2009-06-30 | $-117 |
| 2009-03-31 | $-116 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $88.397B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $45.651B | 17.16 |
| Natera (NTRA) | United States | $23.104B | 0.00 |
| DiDi Global (DIDIY) | China | $21.969B | 0.00 |
| ICON (ICLR) | Ireland | $18.002B | 16.03 |
| Avantor (AVTR) | United States | $14.742B | 22.10 |
| Viatris (VTRS) | United States | $13.929B | 4.29 |
| Revvity (RVTY) | United States | $13.859B | 24.08 |
| BioMerieux (BMXMF) | France | $12.558B | 0.00 |
| CochLear (CHEOY) | Australia | $12.074B | 0.00 |
| Solventum (SOLV) | United States | $11.587B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.906B | 30.72 |
| Doximity (DOCS) | United States | $9.727B | 57.25 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.707B | 0.00 |
| Charles River Laboratories (CRL) | United States | $9.517B | 18.39 |
| HealthEquity (HQY) | United States | $8.694B | 43.62 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.259B | 29.11 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $4.082B | 4.12 |
| Sotera Health (SHC) | United States | $3.713B | 19.86 |
| BrightSpring Health Services (BTSG) | United States | $2.990B | 63.59 |
| Surgery Partners (SGRY) | United States | $2.625B | 29.93 |
| Concentras Parent (CON) | United States | $2.513B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.455B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.277B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.255B | 0.00 |
| Premier (PINC) | United States | $2.006B | 10.44 |
| PACS (PACS) | United States | $1.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.734B | 45.50 |
| Teladoc Health (TDOC) | United States | $1.699B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Progyny (PGNY) | United States | $1.597B | 32.34 |
| Establishment Labs Holdings (ESTA) | $1.282B | 0.00 | |
| CareDx (CDNA) | United States | $1.267B | 0.00 |
| Embecta (EMBC) | United States | $1.132B | 7.92 |
| Pediatrix Medical (MD) | United States | $1.068B | 10.45 |
| AMN Healthcare Services Inc (AMN) | United States | $1.023B | 6.93 |
| Agilon Health (AGL) | United States | $1.001B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.563B | 14.73 |
| SBC Medicals (SBC) | United States | $0.526B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.490B | 0.00 |
| DocGo (DCGO) | United States | $0.416B | 15.69 |
| Sonida Senior Living (SNDA) | United States | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.242B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.234B | 0.00 |
| MultiPlan (MPLN) | United States | $0.206B | 0.00 |
| LifeMD (LFMD) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.197B | 0.00 |
| Beauty Health (SKIN) | United States | $0.192B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| Nutex Health (NUTX) | United States | $0.168B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.70 |
| ModivCare (MODV) | United States | $0.094B | 5.09 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |